Mahamaya Lifesciences Board of Directors

Get the latest insights into the leadership at Mahamaya Lifesciences. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Krishnamurthy Ganesan Managing Director
Mr. Prashant Krishnamurthy Executive Director & CFO
Mrs. Lalitha Krishnamurthy Whole Time Director
Dr. Charudatta Digambar Mayee Independent Director
Dr. Gopal Krishna Raju Independent Director
Mr. Sekhar Kavasseri Rajagopalan Independent Director

Mahamaya Lifesciences Share price

MAHALIFE

00.0

0 (0.00%)
Last updated on 18 Nov, 2025 | 07:50 IST
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

0.00

52 Week High

0.00

The current prices are delayed, login to your account for live prices

Mahamaya Lifesciences FAQs

The board at Mahamaya Lifesciences consists of experienced professionals, including Mr. Krishnamurthy Ganesan , Mr. Prashant Krishnamurthy , and others, overseeing the company’s strategic and corporate governance.

Directors at Mahamaya Lifesciences are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Krishnamurthy Ganesan is the current chairman at Mahamaya Lifesciences.

Executive directors at Mahamaya Lifesciences are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Mahamaya Lifesciences adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Mahamaya Lifesciences, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.